Peakline Partners

Peakline Partners is an SEC-registered investment adviser that provides curated direct private investment opportunities to individual and family office investors. The firm specializes in alternative asset classes including private equity, private credit, real estate, and venture capital. Their investment philosophy emphasizes an agile and opportunistic approach to identify distinctive opportunities that generate substantial, long-term value. Peakline Partners aims to provide access to private market opportunities typically reserved for institutional investors.

Peakline Partners was founded in 2017 by industry veterans Avy Stein and Eric Becker. The firm was initially known as Cresset Partners and rebranded to Peakline Partners in February 2025 to reflect its growth and evolution as an independent entity. It was built on the belief that there are significant opportunities in private markets and that individuals, families, and family offices are often under-allocated in these areas. The founders' previous experience includes starting, nurturing, and backing over 150 businesses and raising more than $8 billion in capital.

Peakline Partners has made numerous investments across various sectors. Notable investments include Alliance Spine and Pain Management, Enveda Biosciences, and CH Investment Partners. Enveda Biosciences is a biotechnology company leveraging AI for drug discovery, in which Peakline Partners participated in a $130 million Series C funding round. The firm also focuses on real estate investments covering multifamily, build-to-rent, office, industrial, and retail properties.

The firm is exclusively owned by its employees and investors, and they invest alongside their investors in each strategy, demonstrating a strong alignment of interests. The team comprises dedicated private investment professionals with deep expertise across private capital, real estate, and venture capital. Co-founders Avy Stein and Eric Becker lead the firm, bringing extensive experience in private markets. Other key team members include Bill Rudnick, Chris Boehm, Michael Miller, and Larry Levy, who hold executive and managing director roles across the firm's various investment strategies.